J. Mel Sorensen
2022
In 2022, J. Mel Sorensen earned a total compensation of $1.4M as President and Chief Executive Officer at Galera Therapeutics, a 46% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $295,446 |
|---|---|
| Option Awards | $453,096 |
| Salary | $596,860 |
| Other | $16,045 |
| Total | $1,361,448 |
Sorensen received $596.9K in salary, accounting for 44% of the total pay in 2022.
Sorensen also received $295.4K in non-equity incentive plan, $453.1K in option awards and $16K in other compensation.
Rankings
In 2022, J. Mel Sorensen's compensation ranked 2,435th out of 5,760 executives tracked by ExecPay. In other words, Sorensen earned more than 57.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,435 out of 5,760 | 58th |
Division Manufacturing | 1,334 out of 3,136 | 58th |
Major group Chemicals And Allied Products | 602 out of 1,422 | 58th |
Industry group Drugs | 556 out of 1,323 | 58th |
Industry Pharmaceutical Preparations | 400 out of 969 | 59th |
Source: SEC filing on April 27, 2023.
Sorensen's colleagues
We found three more compensation records of executives who worked with J. Mel Sorensen at Galera Therapeutics in 2022.
News
Galera Therapeutics CEO J Sorensen's 2023 pay slips 8% to $1.3M
January 24, 2025
Galera Therapeutics CEO J Sorensen's 2022 pay falls 46% to $1.4M
April 27, 2023
Galera Therapeutics CEO J Sorensen's 2021 pay slips 14% to $2.5M
April 28, 2022
Galera Therapeutics CEO J Sorensen's 2019 pay jumps 373% to $2.5M
April 27, 2020